![Ted Slocomb](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ted Slocomb
Keine laufenden Positionen mehr
Profil
Mr. Slocomb joined Bear Stearns Health Innoventures from the CNS/Metabolic Franchise of Ortho-McNeil Pharmaceutical, a division of Johnson & Johnson.
At Ortho-McNeil Pharmaceutical, his responsibilities included new product planning and commercial evaluations of product acquisition and in-licensing opportunities in metabolic disease as well as lifecycle management initiatives in neurology.
Prior to BASF Pharma, at Bogart Delafield Ferrier, Mr. Slocomb was a strategy consultant to leading pharmaceutical and biopharmaceutical companies, including Genentech, Pfizer, Hoechst Marion Roussel, GlaxoWellcome, SmithKline Beecham, and Bristol-Myers Squibb.
Assignments included product launch and marketing strategy formulation, repositioning of under-performing products, R&D portfolio evaluation and prioritization, post-acquisition integration of R&D assets and technology in-licensing/acquisition screening and assessment.
Mr. Slocomb earned a BA in Genetics from the University of California at Berkeley and an MBA in Finance from the Stern School of Business at New York University (Stern Scholar, Beta Gamma Sigma).
Ehemalige bekannte Positionen von Ted Slocomb
Unternehmen | Position | Ende |
---|---|---|
Bear Stearns Health Innoventures Management LLC
![]() Bear Stearns Health Innoventures Management LLC Investment ManagersFinance A subsidiary of Bear Stearns Asset Management, Inc., Bear Stearns Health Innoventures Management LLC (BSHI) is a venture capital firm headquartered in New York City. | Private Equity Investor | 31.03.2009 |
BASF Pharma Ltd.
![]() BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Bear Stearns Health Innoventures Management LLC
![]() Bear Stearns Health Innoventures Management LLC Investment ManagersFinance A subsidiary of Bear Stearns Asset Management, Inc., Bear Stearns Health Innoventures Management LLC (BSHI) is a venture capital firm headquartered in New York City. | Finance |
BASF Pharma Ltd.
![]() BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Health Technology |